Table 5.
Guideline Agreement and Experience with Genetic Testing for Cancer Risk (n = 35,116)
| Number of guidelines for which a woman was defined as high risk (% affirmative response) | RR (95% CI) * | ||||||
|---|---|---|---|---|---|---|---|
| 0 | 1 | 2 | 3 | 1 vs 0 | 2 vs 0 | 3 vs 0 | |
| Heard of genetic testing for cancer risk | 42 | 53 | 55 | 58 | 1.3 (1.1-1.5) | 1.3 (1.1-1.6) | 1.4 (0.9-2.2) |
| Discussed testing with health professional | 2.0 | 8.4 | 10.9 | 32.4 | 4.2 (2.5-7.2) | 5.4 (3.3-8.8) | 16.1 (7.4-35.0) |
| Advised by health professional to be tested | 0.71 | 4.79 | 3.07 | 14.29 | 6.7 (2.9-15.4) | 4.3 (1.8-10.2) | 20.0 (3.5-114.3) |
| Had a genetic test for breast or ovarian cancer risk | 0.21 | 0.73 | 2.65 | 0 | 3.5 (0.5-26.0) | 12.7 (4.4-36.8) | NA † |
*RR = relative risk adjusted for survey year
†Statistic not available due to 0 cell count